Renalase contributes to protection against renal fibrosis via inhibiting oxidative stress in rats

Background Renal interstitial fibrosis (RIF) is a common pathway for progression of chronic kidney disease (CKD) to end-stage renal disease. In our previous study, it has been provided that renalase can ameliorate renal interstitial fibrosis in unilateral ureteral obstruction (UUO) rats. The other m...

Full description

Saved in:
Bibliographic Details
Published inInternational urology and nephrology Vol. 50; no. 7; pp. 1347 - 1354
Main Authors Wu, Yiru, Wang, Liyan, Wang, Xiaoqi, Wang, Yahui, Zhang, Qidong, Liu, Wenhu
Format Journal Article
LanguageEnglish
Published Dordrecht Springer Netherlands 01.07.2018
Springer Nature B.V
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Background Renal interstitial fibrosis (RIF) is a common pathway for progression of chronic kidney disease (CKD) to end-stage renal disease. In our previous study, it has been provided that renalase can ameliorate renal interstitial fibrosis in unilateral ureteral obstruction (UUO) rats. The other mechanism of renalase to alleviate renal fibrosis should be explored. Materials and methods In this study, we evaluated the role of oxidative stress in UUO rats and epithelial–mesenchymal transition (EMT) in human proximal renal tubular epithelial (HK-2) cells and examined the association of renalase. Results Oxidative stress could induce EMT and fibrosis in HK-2 cells. In the UUO model, oxidative stress occurred and maintained at a high level leading to RIF. Administration of renalase by adenovirus significantly attenuated oxidative stress and further in vitro study showed that renalase can exert anti-fibrosis by inhibiting oxidative stress. Conclusion Our results prompt another mechanism of anti-fibrotic renal protection of renalase, which may be partly associated with inhibiting oxidative stress. These data provided another theoretical basis that supplementation with exogenous renalase may be a promising strategy for slowing or halting the progression of CKD.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0301-1623
1573-2584
DOI:10.1007/s11255-018-1820-2